These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15510514)

  • 1. [The effectiveness of latanoprost for the treatment of pediatric glaucoma].
    Urban B; Bakunowicz-Lazarczyk A; Mrugacz M; Oziebło-Kupczyk M
    Klin Oczna; 2004; 106(1-2 Suppl):243-4. PubMed ID: 15510514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latanoprost for the treatment of pediatric glaucoma.
    Enyedi LB; Freedman SF
    Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S129-32. PubMed ID: 12204709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latanoprost in pediatric glaucoma--pediatric exposure over a decade.
    Black AC; Jones S; Yanovitch TL; Enyedi LB; Stinnett SS; Freedman SF
    J AAPOS; 2009 Dec; 13(6):558-62. PubMed ID: 20006816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of latanoprost and timolol in pediatric glaucoma: a phase 3, 12-week, randomized, double-masked multicenter study.
    Maeda-Chubachi T; Chi-Burris K; Simons BD; Freedman SF; Khaw PT; Wirostko B; Yan E;
    Ophthalmology; 2011 Oct; 118(10):2014-21. PubMed ID: 21680022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latanoprost : an update of its use in glaucoma and ocular hypertension.
    Perry CM; McGavin JK; Culy CR; Ibbotson T
    Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of additive preoperative latanoprost treatment on the outcome of filtration surgery.
    Berthold S; Pfeiffer N
    Graefes Arch Clin Exp Ophthalmol; 2006 Aug; 244(8):1029-34. PubMed ID: 16341541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of travoprost, latanoprost, and the fixed combination of dorzolamide and timolol in patients with pseudoexfoliation glaucoma.
    Parmaksiz S; Yüksel N; Karabas VL; Ozkan B; Demirci G; Caglar Y
    Eur J Ophthalmol; 2006; 16(1):73-80. PubMed ID: 16496249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and efficacy of a mass switch from latanoprost to bimatoprost in glaucoma patients in a prepaid Health Maintenance Organization.
    Law SK; Song BJ; Fang E; Caprioli J
    Ophthalmology; 2005 Dec; 112(12):2123-30. PubMed ID: 16225924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the use of latanoprost for glaucoma since its launch.
    Digiuni M; Fogagnolo P; Rossetti L
    Expert Opin Pharmacother; 2012 Apr; 13(5):723-45. PubMed ID: 22348427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of benzalkonium chloride-free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study.
    Lopes JF; Hubatsch DA; Amaris P
    BMC Ophthalmol; 2015 Nov; 15():166. PubMed ID: 26563363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-year follow-up of latanoprost 0.005% monotherapy after changing from previous glaucoma therapies.
    Bayer A; Weiler W; Oeverhaus U; Skrotzki FE; Stewart WC;
    J Ocul Pharmacol Ther; 2004 Dec; 20(6):470-8. PubMed ID: 15684807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study.
    Katz LJ; Rauchman SH; Cottingham AJ; Simmons ST; Williams JM; Schiffman RM; Hollander DA
    Curr Med Res Opin; 2012 May; 28(5):781-8. PubMed ID: 22458918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, 36-month, post-marketing efficacy and tolerability study in Sweden and Finland of latanoprost versus non-prostaglandin therapy in patients with glaucoma or ocular hypertension.
    Friström B; Uusitalo H
    Acta Ophthalmol; 2010 Feb; 88(1):37-43. PubMed ID: 19900212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of single glaucoma drug in combined timolol XE, latanoprost and brinzolamide therapy: a discontinuation study.
    Kobayashi H
    J Ocul Pharmacol Ther; 2012 Jun; 28(3):245-50. PubMed ID: 22283238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost.
    Gandolfi SA; Cimino L
    Ophthalmology; 2003 Mar; 110(3):609-14. PubMed ID: 12623831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Five years retrospective study of latanoprost glaucoma treatment].
    Závorková M; Susický P
    Cesk Slov Oftalmol; 2007 Jul; 63(4):292-8. PubMed ID: 17682609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latanoprost in port wine stain related paediatric glaucoma.
    Ong T; Chia A; Nischal KK
    Br J Ophthalmol; 2003 Sep; 87(9):1091-3. PubMed ID: 12928274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of age, diagnosis, and history of glaucoma surgery on outcomes in pediatric patients treated with latanoprost.
    Maeda-Chubachi T; Chi-Burris K; Simons B; Brémond-Gignac D; Freedman S; Khaw PT; Wirostko B; Yan E;
    J Glaucoma; 2013; 22(8):614-9. PubMed ID: 23524858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
    Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of latanoprost on intraocular pressure during 12 months of treatment for normal-tension glaucoma.
    Oh JY; Park KH
    Korean J Ophthalmol; 2005 Dec; 19(4):297-301. PubMed ID: 16491821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.